Where Can You Get Cinqair IV Therapy for Asthma in Edgewater, MD?

At Jean Walter Infusion Center, we are committed to offering advanced therapies for patients with complex medical needs, including those suffering from severe eosinophilic asthma. One such innovative treatment available at our center is Cinqair (reslizumab) infusion therapy.

Cinqair is a targeted medication designed for individuals with severe eosinophilic asthma—a form of asthma marked by elevated levels of eosinophils, a type of white blood cell involved in airway inflammation. When eosinophils accumulate in the lungs, they can cause persistent inflammation and asthma symptoms that are difficult to manage with standard inhaled treatments.

Cinqair is a monoclonal antibody that directly targets interleukin-5 (IL-5), a protein responsible for the growth and survival of eosinophils. By blocking IL-5, Cinqair reduces the number of eosinophils in the airways and bloodstream, helping to decrease inflammation. This can lead to fewer asthma attacks, improved lung function, and better overall control of asthma symptoms.

Cinqair is administered as an intravenous (IV) infusion, typically once every four weeks. At Jean Walter Infusion Center, our experienced medical staff ensure that each infusion is provided in a comfortable, supportive, and closely monitored environment. Our team works closely with your pulmonologist or asthma specialist to develop a personalized treatment plan tailored to your needs.

Cinqair infusion therapy is most effective for patients with high eosinophil counts whose asthma is not adequately controlled by inhaled corticosteroids and other standard medications. If you continue to experience frequent asthma symptoms or exacerbations despite optimal therapy, Cinqair may help you achieve better symptom control and reduce your need for oral steroids or hospitalizations.

When you arrive for your Cinqair (reslizumab) IV infusion at Jean Walter Infusion Center, our friendly clinic staff will greet you and assist with the check-in process. One of our experienced nurses or healthcare providers will review your medical history, confirm your current medications, and ask about any recent health changes or allergies. You’ll also have the opportunity to ask questions and share any concerns you may have about your upcoming infusion.

Our team will help you get settled comfortably in one of our infusion chairs or beds, as the Cinqair infusion typically takes about 20 to 50 minutes. Your nurse will place an intravenous (IV) line, usually in your arm, to administer the medication. Before starting, we’ll check your vital signs, including blood pressure, pulse, and temperature, to ensure everything is within a safe range.

Throughout your infusion at Jean Walter Infusion Center, you’ll be closely monitored by our attentive nursing staff for any signs of side effects or allergic reactions, such as rash, itching, swelling, or trouble breathing. Most patients tolerate Cinqair infusions very well, and our team will be by your side to ensure your comfort and safety. You are welcome to read, use your phone, or simply relax during the infusion.

Once your infusion is complete, your nurse will remove the IV. For your safety, we’ll ask you to stay for a short observation period—usually about 30 minutes—to watch for any delayed reactions. Before you leave, your provider will check in with you to discuss how you’re feeling, review any symptoms to watch for at home, and answer any final questions. We’ll also confirm your next appointment to ensure your treatment continues seamlessly.

At Jean Walter Infusion Center, we offer Cinqair (reslizumab) IV therapy as part of our comprehensive care for adults with severe eosinophilic asthma. Cinqair is administered as an intravenous infusion by our experienced medical team in a comfortable and supportive clinical environment.

What to Expect at Jean Walter Infusion Center:

• Personalized Scheduling: Cinqair infusions are typically given once every four weeks, and our staff will work with you to arrange convenient monthly appointments that fit your schedule.

• Expert Administration: Each infusion is performed by skilled healthcare professionals who specialize in IV therapies, ensuring your experience is as safe and pleasant as possible.

• Ongoing Monitoring: During and after your infusion visits, our team will carefully monitor your response to treatment and check for any side effects, making adjustments to your care plan as needed.

• Comprehensive Support: We coordinate closely with your referring asthma specialist to ensure your therapy remains effective and tailored to your individual needs.

• Comfort and Care: Our infusion center is designed to provide a relaxing and patient-centered environment, supporting your comfort throughout your treatment.

If you have severe eosinophilic asthma and your doctor has recommended Cinqair, the Jean Walter Infusion Center is here to guide you through every step of your infusion therapy.

At Jean Walter Infusion Center, your safety and well-being are our top priorities as we prepare you for Cinqair (reslizumab) infusion therapy. Before starting Cinqair, several important steps are taken by our clinical team to ensure that this treatment is the best option for you:

• Confirming Eligibility:
Cinqair is indicated for adults (18 years and older) with severe eosinophilic asthma that is not adequately controlled with standard asthma medications. Our team will carefully review your medical history and recent laboratory results—especially your blood eosinophil count—to confirm that Cinqair is appropriate for you.

• Allergy and Hypersensitivity Assessment:
Before your first infusion, we will discuss any history of allergic reactions, especially to reslizumab or any of its components. Serious allergic reactions, including anaphylaxis, have been reported with Cinqair. Our infusion center is fully equipped to monitor and manage any immediate reactions.

• Review of Health History:
Your overall health is important to us. Please inform our staff about any history of parasitic (helminth) infections, as these may be more challenging to treat while on Cinqair. We will also review your current and past medical conditions to ensure infusion safety.

• Medication Review:
Our clinical pharmacists will review your current medications to check for any potential interactions. While Cinqair is generally compatible with most asthma medications, a thorough review helps us provide the safest care.

• Infusion Scheduling and Adherence:
Cinqair is administered as an intravenous (IV) infusion once every four weeks at Jean Walter Infusion Center. We will work with you to schedule regular appointments and discuss the importance of maintaining this infusion schedule for the best possible results.

• Special Populations:
If you are pregnant, planning to become pregnant, or breastfeeding, please let us know. There is limited information about the safety of Cinqair in these groups, and we will help you weigh the risks and benefits.

• Immunization Status:
We will review your immunization history, as live vaccines should generally be avoided while receiving biologic therapies like Cinqair.

• Shared Decision-Making:
Before your first infusion, our team will discuss the potential benefits and risks of Cinqair, including possible side effects such as muscle pain, throat discomfort, and a small increased risk of cancer observed in some studies. We encourage you to ask questions and take an active role in your treatment decisions.

• Ongoing Monitoring:
Regular follow-up visits at Jean Walter Infusion Center will help us monitor your response to therapy and manage any side effects. Our experienced staff is always available to address any concerns during your treatment journey.

At Jean Walter Infusion Center, Dr. Nasseri, MD, and his team are dedicated to providing exceptional care and support for patients managing severe asthma with Cinqair (reslizumab) intravenous (IV) therapy. Our state-of-the-art infusion center is staffed by a specialized team of nurses and healthcare professionals experienced in administering Cinqair and other advanced IV medications.

When you choose the Jean Walter Infusion Center for your Cinqair infusions, you can expect:

• Expert Care: Our infusion nurses are highly trained in asthma biologic therapies and will carefully monitor you before, during, and after your infusion to ensure your safety and comfort.

• Patient Education: We believe in empowering our patients through knowledge. Our team will walk you through each step of the infusion process, explain what to expect at every visit, and educate you about possible side effects—so you know when and how to reach out for help.

• Personalized Support: We offer a welcoming and supportive environment where you can ask questions and express any concerns about your therapy. Your well-being is always our top priority.

• Convenient Scheduling: We understand that your time is valuable. Our flexible appointment options are designed to fit your schedule and minimize disruptions to your daily life.

• Coordinated Care: Our staff collaborates closely with your referring physician and asthma specialist to ensure seamless communication and continuity of care, optimizing your treatment outcomes.

At the Jean Walter Infusion Center, our goal is to make your Cinqair IV therapy as comfortable and effective as possible, helping you manage your severe asthma with confidence and peace of mind. For more information, contact us or request an appointment online. We are conveniently located at 3168 Braverton St., Suite 330A, Edgewater, MD 21037. We serve patients from Edgewater MD, Riva MD, Davidsonville MD, Annapolis MD, and surrounding areas.